Pages that link to "Q67753063"
Jump to navigation
Jump to search
The following pages link to Antithrombin III Level, Fibrinogen Level, and Platelet Count Changes With Adjuvant Tamoxifen Therapy (Q67753063):
Displaying 22 items.
- Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer (Q24685693) (← links)
- Tamoxifen and risk of idiopathic venous thromboembolism (Q28368257) (← links)
- Tamoxifen-associated portal vein thrombosis causing severe oesophageal variceal bleeding. (Q33166159) (← links)
- Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer (Q33560280) (← links)
- Clinical pharmacology of selective estrogen receptor modulators (Q33688752) (← links)
- Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug. (Q33739214) (← links)
- Chemoprevention of breast cancer: implications for postmenopausal women (Q34585121) (← links)
- Meta-analysis of vascular and neoplastic events associated with tamoxifen (Q34742590) (← links)
- Efficacy and economics of hormonal therapies for advanced breast cancer (Q34767513) (← links)
- Tamoxifen-associated vasculitis in a breast cancer patient (Q35613567) (← links)
- Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021. (Q35800558) (← links)
- Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women (Q36383775) (← links)
- Update on the use of aromatase inhibitors in early-stage breast cancer (Q37467243) (← links)
- Tamoxifen as adjuvant therapy in breast cancer. Current status (Q40385706) (← links)
- A risk-benefit assessment of tamoxifen therapy (Q40912737) (← links)
- Tamoxifen in postmenopausal women a safety perspective (Q41232544) (← links)
- Protein S and protein C level changes with adjuvant tamoxifen therapy in postmenopausal women (Q42282807) (← links)
- Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis (Q42538550) (← links)
- Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina (Q45265962) (← links)
- Effects of chemoendocrine therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer. Japan Advanced Breast Cancer Study Group and Japan Clinical Oncology Group (Q70769303) (← links)
- Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen (Q72783702) (← links)
- Chronic subdural haematoma: a possible relationship with tamoxifen (Q77763940) (← links)